Zheng-Ting Qian
Papers
1
Total Citations
5
H-Index
1
About
Zheng-Ting Qian is a clinician-researcher specializing in neurosurgical oncology and advanced diagnostic neuroimaging. His work centers on improving the accuracy and safety of brain tumor diagnosis, particularly for challenging conditions like primary central nervous system lymphoma (PCNSL). Qian’s most notable contribution is his pioneering application of multimodal imaging combined with frameless robotic stereotactic biopsy, a technique that integrates multiple imaging modalities—such as MRI, CT, and PET—to precisely guide robotic-assisted tissue sampling. In a landmark 2022 study, he demonstrated this approach’s feasibility in a small cohort of suspected PCNSL patients, achieving a 100% diagnostic yield with no major complications. While his citation count is still growing (5 citations for this key paper), the work has been recognized for its potential to reduce the need for invasive open biopsies and improve diagnostic accuracy in complex CNS lesions. Qian’s research bridges cutting-edge robotics with clinical neuropathology, offering a safer, more precise pathway for diagnosing brain lymphomas and other deep-seated tumors. His ongoing efforts aim to expand this technique to larger, multicenter trials, positioning him as an emerging leader in minimally invasive neurosurgical diagnostics.
Research Focus
Key Achievements
Top Papers
- 1